GRI Bio, Inc. Files S-1 for Securities Registration
Ticker: GRI · Form: S-1 · Filed: Mar 25, 2025 · CIK: 1824293
Sentiment: neutral
Topics: sec-filing, s-1, registration
TL;DR
GRI Bio (fka Vallon Pharma) filed S-1 for public offering. Get ready.
AI Summary
GRI Bio, Inc. filed an S-1 form on March 25, 2025, to register its securities. The company, formerly known as Vallon Pharmaceuticals, Inc. until April 24, 2023, is based in La Jolla, California. GRI Bio, Inc. operates in the Pharmaceutical Preparations sector.
Why It Matters
This S-1 filing indicates GRI Bio, Inc. is preparing to offer its securities to the public, which could lead to new investment opportunities and increased trading activity.
Risk Assessment
Risk Level: medium — S-1 filings are typically associated with new public offerings, which carry inherent market and execution risks.
Key Players & Entities
- GRI Bio, Inc. (company) — Filer of the S-1 registration statement
- Vallon Pharmaceuticals, Inc. (company) — Former name of GRI Bio, Inc.
- 20250325 (date) — Date of S-1 filing
- La Jolla, CA (location) — Business address of GRI Bio, Inc.
FAQ
What is the purpose of this S-1 filing by GRI Bio, Inc.?
The S-1 filing is a registration statement filed with the SEC to register securities for public offering.
When was GRI Bio, Inc. formerly known as Vallon Pharmaceuticals, Inc.?
GRI Bio, Inc. was formerly known as Vallon Pharmaceuticals, Inc. until April 24, 2023.
What is the business address of GRI Bio, Inc.?
The business address of GRI Bio, Inc. is 2223 Avenida De La Playa, Suite 208, La Jolla, CA 92037.
What is the Standard Industrial Classification (SIC) code for GRI Bio, Inc.?
The SIC code for GRI Bio, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
On what date was this S-1 filing submitted?
This S-1 filing was submitted on March 25, 2025.
Filing Details
This Form S-1 (Form S-1) was filed with the SEC on March 25, 2025 regarding GRI Bio, Inc. (GRI).